CDC Website CDC Website

To Join the NPIN community or

Home » Limited Interaction Targeted Epidemiology (LITE) to Advance HIV Prevention (UG3/UH3)

Limited Interaction Targeted Epidemiology (LITE) to Advance HIV Prevention (UG3/UH3)

The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications to use innovative technology to conduct epidemiologic studies of large cohorts of U.S. populations at high risk of HIV infection: men who have sex with men (MSM), transgender women, and black/African American women. The UG3/UH3 Phased Innovation Awards Cooperative Agreement involves 2 phases. Funding for a UG3 phase will be used to enroll and follow sufficient numbers of high-risk HIV-negative participants to reach seroconversion milestone targets. A UG3 project that meets its milestones will be administratively considered by NIAID and prioritized for transition to the UH3 award. Applicants responding to this FOA must address objectives for both the UG3 and UH3 phases.

Fund Location Notes
Eligible Organizations
Number of Awards Given
3-4 awards

Minimum Amount: 


Maximum Amount: 


Average Amount: 


Award Amount: 

Award Amount Notes
The following NIH components intend to commit the following amounts in FY 2017 to fund 3-4 awards: NIAID, $3.6 million; NIMH, $0.5 million.
Letter of Intent Date
Application Due Date
Award Date
Open Ended Date
Project Start Date
Application Contact
Sharp, Dr.P.H.
National Institute of Allergy and Infectious Diseases
United States
(240) 627-3217
(240) 627-3217
Technical Contact
United States
(301) 435-0714
(301) 435-0714
Fund Duration
The scope of the proposed project should determine the project period. The project period may be up to 5 years: up to 2 years for the first phase (UG3) and up to 3 years for the second phase (UH3).
Application Process
Applicants must obtain the SF424 (R&R) application package associated with this funding opportunity using the “Apply for Grant Electronically” button in the FOA or following the directions provided at
Focus Area

Fund Number: 


Fund ID: 


Last Updated: